Daily News

SVB Financial Group to Redeem All $350 Million Of Its 5.375% Senior Notes Due 2020

SVB Financial Group (SIVB) Friday night announced plans to redeem all $350 million of its 5.375% senior notes due 2020, paying the face value of the notes plus either the combined value of the remaining interest payment due on the notes or an amount equal to the interest rate paid for a yet-to-be-selected Treasury security plus 45 basis points. Additional […]

Mondelez International Issues Recall on Certain Cheese Nips Products

Mondelez International (MDLZ) on Friday issued a voluntary recall of a limited quantity of its Cheese Nips product in the US. According to a statement, the recall is limited exclusively to the company’s 11 oz. box of Cheese Nips with a retail universal product code of 044000034535, with expiration dates of May 18, 19, and 20, 2020. The company said […]

Alliance Resource Partners Issues Plant Closing Notice to 185 Workers at Gibson North Coal Mine- Stock Up 3%

Alliance Resource Partners (ARLP) said on Friday its subsidiary, Gibson County Coal, has notified 185 workers of plant closing following the idling of its Gibson North coal mine used to supply the global coal markets. “The export markets have deteriorated over the last seven months and have contributed to an over-supplied domestic market,” said CEO Joseph Craft. “This production response […]

Peabody Energy Discloses Stake in Dell

Elliott Management disclosed its recent stake in Dell Technologies (DELL), Peabody Energy (BTU) and Arconic (ARNC) during the quarter ended September, according to a Thursday filing. The investment management firm currently has a total of 17.15 million shares in Dell, 28,916,201 shares in Peabody, and 41,565,658 shares in Arconic. Elliott’s stake in Dell and Peabody, respectively, was increased to 5.62% […]

CorMedix Q3 Loss Widens From Year Ago

CorMedix (CRMD) on Thursday widened its net loss to $1.35 per share in Q3 from $0.54 per share a year earlier, while forecasting possible approval of its experimental drug Neutrolin to prevent bloodstream infections next year. Two analysts polled by Capital IQ expected a net loss of $0.25 per share for the quarter. “We have entered the home stretch towards […]

BeiGene Wins US FDA Accelerated OK for Brukinsa for Mantle Cell Lymphoma Treatment

BeiGene (BGNE), a commercial-stage biopharmaceutical company, said late Thursday that Brukinsa won accelerated approval from the US FDA as a treatment for mantle cell lymphoma (MCL) in adult patients who have received at least one prior therapy. Brukinsa is the first BeiGene-discovered product to receive approval, will be available to people in the US in the coming weeks, the company […]

Nordstrom Joins Consortium in $10 Million Funding for Plus-Size Luxury Fashion Firm 110 Honore

Nordstrom (JWN) is part of a $10 million funding group for plus-size luxury fashion company, 110 Honore, various media reported on Thursday. The investment led by Greycroft Partners with other investors including Forerunner Ventures and Upfront Ventures will be used for expansion of its personal styling and shopping service and more brands on its site, Chain Store Age reported, citing […]

Dollar Tree Issued FDA Warning Letter for Allegedly Receiving OTC Drugs From Law-Violating Manufacturers

Dollar Tree (DLTR) has been issued a warning letter from the US Food and Drug Administration for allegedly receiving over-the-counter drugs produced by foreign manufacturers found to have “serious violations of federal law,” according to a statement from the agency. The FDA issued the warning to Greenbrier International, doing business as Dollar Tree. The letter outlines alleged violations of manufacturing […]

Biogen Slips After National Multiple Sclerosis Society Takes Issue With $88,000 Annualized Vumerity Pricing

Shares of Biogen (BIIB) were down about 3% in late trading Thursday after the National Multiple Sclerosis Society said the pricing of Vumerity at an annualized price of $88,000 has failed to show a “commitment to affordable access.” The advocacy group said that Biogen and its partner Alkermes, which had initially developed the compound, said the decision to launch the […]